Sanjivani Paranteral is currently trading at Rs. 55.83, up by 2.65 points or 4.98% from its previous closing of Rs. 53.18 on the BSE.
The scrip opened at Rs. 55.83 and has touched a high and low of Rs. 55.83 and Rs. 55.83 respectively. So far 2140 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 67.40 on 13-Sep-2022 and a 52 week low of Rs. 24.80 on 24-Mar-2023.
Last one week high and low of the scrip stood at Rs. 57.00 and Rs. 51.30 respectively. The current market cap of the company is Rs. 53.17 crore.
The promoters holding in the company stood at 29.88%, while Institutions and Non-Institutions held 14.23% and 55.89% respectively.
Sanjivani Paranteral has entered into a partnership with a reputable organization Aievia Helathcare s.r.o. in Prague, Czech Republic to launch a new project that aims to cater the requirements of the Pharma markets of European Union. This initiative has excellent prospects for growth and will help the company expand its business operations in the-EU markets.
Sanjivani Paranteral is a research-based, international pharmaceutical company that provides a wide range of high quality products and services at affordable prices.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |